Guides
Long-form, dietitian-written, physician-reviewed
Practical playbooks for everyday GLP-1 life — eating, side effects, switching, travel, and the friction nobody warns you about.
Cost + access
Cheapest GLP-1 in 2026: how to get Wegovy, Zepbound & Ozempic for less
Wegovy and Zepbound list near $1,000-1,600/month. Almost nobody pays that. This is the complete, honest menu of the cheapest ways to get a GLP-1 in 2026 — manufacturer cards, insurance appeals, compounded telehealth — ranked by how much they actually save, with every price sourced.
15 min read
Weight management
Is Wegovy working? The 5%-at-16-weeks marker that clinicians actually use
You do not have to wait 68 weeks to know. STEP-1 (NEJM 2021) established the clinical marker still used today: ≥5% body-weight loss by week 16 predicts long-term response. This guide walks through the marker, the decision tree if you miss it, and the non-scale signals that also matter.
8 min read
Weight management
GLP-1 washout before pregnancy: what the FDA labels + ACOG say + the honest half-life math
Both the Wegovy and Ozempic labels say discontinue at least 2 months before a planned pregnancy. This guide explains what that means in half-life terms, what the FDA-approved evidence supports, and what to do if you are already pregnant on semaglutide or tirzepatide. Sourced to FDA labels + the ACOG Committee Opinion on obesity in pregnancy.
9 min read
Weight management
GLP-1 rebound weight gain: what STEP-4 and SURMOUNT-4 actually show — and how to prevent it
Two randomized trials answer the question directly: what happens when you stop semaglutide or tirzepatide? Roughly two-thirds of the weight lost comes back within a year. This guide translates STEP-4 (JAMA 2021), SURMOUNT-4 (NEJM 2024), and the AACE 2024 obesity guidelines into an evidence-based prevention playbook.
10 min read
Weight management
Wegovy results: the week-by-week STEP-1 milestones you should actually expect
Not a generic month-by-month guide. This is what the STEP-1 trial (NEJM 2021) actually observed in 1961 patients on Wegovy over 68 weeks — dose-by-dose weight-loss milestones, side-effect timing by titration step, and where the plateaus really are. Cited to the primary source.
11 min read
Perioperative
Stopping GLP-1s before surgery: the 2026 anesthesia protocol
Delayed gastric emptying on Ozempic, Wegovy, Mounjaro, or Zepbound is an anesthesia problem, not a general-safety one. Here is the current multi-society hold guidance, when it applies, and what to tell your surgeon.
6 min read
Off-label use
GLP-1 microdosing: what the evidence says (and does not) about below-label doses
Microdosing — taking below-label GLP-1 doses to reduce side effects, save money, or "gentle-start" — is having a 2026 moment. Here is what we actually know about efficacy, what the specific pen-splitting risks are, and the on-label alternative that gets you the same outcome without the tradeoffs.
6 min read
Injection technique
GLP-1 pen not working: manufacturer troubleshoot for Wegovy, Ozempic, Zepbound, Mounjaro
A stuck dial, a click without dose, cloudy solution, or a broken needle hub each has a specific fix. Here is the manufacturer-sourced troubleshoot, when to call the pharmacy for a replacement, and when the pen is fine and it is actually your technique.
6 min read
Body composition
Loose skin after GLP-1 weight loss: what actually retracts, what needs surgery
How much loose skin you end up with is mostly a function of how much you lost, how fast, and how old you were when you lost it. Here is what the actual studies show, the non-surgical protocol that helps, and when the answer really is body-contouring surgery.
8 min read
Getting started
GLP-1 for men: what is different, what is the same, and what providers cater to men
GLP-1 marketing skews heavily female, but men respond to the drugs equally well — sometimes better. Here is what differs (testosterone, muscle, cardiovascular angle) and what stays the same (eligibility, dosing, side effects).
6 min read
Weight management
What happens when you stop a GLP-1: the regain timeline and how to minimize it
Stopping a GLP-1 leads to ~50% regain within 12 months for most patients. That is not failure — it is the disease coming back. Here is the realistic timeline, what drives it, and the four interventions that meaningfully slow it.
6 min read
Medications
Wegovy vs Zepbound in 2026: which is right for you?
Both are FDA-approved for chronic weight management. Both are weekly injections. But Zepbound is a dual GLP-1/GIP agonist and produces ~47% greater relative weight loss in head-to-head trials. Here is when each is the right choice.
7 min read
Side effects
GLP-1 and "food noise": why the cravings stop and what it actually feels like
"Food noise" is the constant intrusive thought-loop about food. GLP-1 medications turn it off for ~80% of patients. Here is the mechanism, the experience, and what it means for long-term outcomes.
5 min read
Weight management
How long does it take to lose weight on a GLP-1? The realistic month-by-month timeline
Marketing photos compress 18 months into one image. Real-world GLP-1 weight loss follows a predictable, slower-than-you-think arc. Here is what to actually expect at month 1, 3, 6, and 12.
6 min read
Medications
Is compounded semaglutide still legal in 2026? The current state of the FDA rules
FDA proposed excluding semaglutide and tirzepatide from 503B bulk substance lists on April 30, 2026. The comment period closes June 29. Here is what that means for patients currently on compounded GLP-1s and how to plan ahead.
7 min read
Nutrition
Free 7-day GLP-1 meal plan: high-protein, GI-friendly, by a dietitian
A free, downloadable 7-day meal plan designed for week-one GLP-1 patients. 100g+ protein per day, 1,500 kcal, GI-friendly portions, full grocery list. RD-written, MD-reviewed.
5 min read
Sleep apnea
Zepbound for sleep apnea: the first FDA-approved GLP-1 for OSA
In December 2024, Zepbound (tirzepatide) became the first GLP-1 medication FDA-approved for moderate-to-severe obstructive sleep apnea. Here is what that means for treatment, insurance coverage, and whether you can replace your CPAP.
7 min read
PCOS
GLP-1 for PCOS in 2026: what the evidence says about Ozempic, Wegovy, and insulin resistance
PCOS affects roughly 1 in 10 women of reproductive age. GLP-1 medications are not FDA-approved for PCOS — but a growing body of evidence supports their off-label use for insulin resistance, weight management, and cycle regulation.
8 min read
Side effects
Ozempic face, hair loss, and skin sagging: what to know and how to prevent it
Rapid weight loss on a GLP-1 can leave behind sunken cheeks, thinning hair, and loose skin. Here is what is actually happening, what to expect, and the four interventions that meaningfully reduce these changes.
9 min read
Insurance & coverage
GLP-1 insurance denied? The appeal guide that gets 60-80% of denials overturned
More than half of GLP-1 prior auth requests are initially denied. Documentation makes the difference — patients with complete appeal packets win 60-80% of cases. Here is exactly what to file.
7 min read
Getting started
How to get prescribed a GLP-1: eligibility, telehealth, and what to expect
Three pathways to a GLP-1 prescription, BMI and comorbidity requirements, what happens at the consultation, what labs are typically ordered, and how to maximize approval odds.
7 min read
Insurance & coverage
Medicare GLP-1 Bridge program 2026: who qualifies, what is covered, how to enroll
CMS launches the Medicare GLP-1 Bridge program July 1, 2026 — $50/month copay for eligible beneficiaries. Here is exactly who qualifies, which drugs are covered, and how to enroll before the deadline.
8 min read
Nutrition
The best foods to eat on Ozempic, ranked by a dietitian
When your appetite is dimmed, every bite has to earn its place. These are the highest-leverage foods I recommend to patients starting semaglutide.
6 min read
Weight management
How to eat in a calorie deficit on GLP-1: tips from a dietitian
GLP-1 medications take the edge off appetite — but a sustainable calorie deficit still requires planning. Here is what a registered dietitian recommends for the people she sees in clinic.
9 min read
Side effects
How to inject your GLP-1 painlessly: 8 tips that actually work
The needles are tiny but technique matters. Here is the protocol that takes injection pain from a 6/10 to a 1/10 for most patients.
4 min read
Weight management
Hit a plateau on your GLP-1? Here is how to break through it
Almost every patient hits a 2-4 week stall around month 4. These are the moves that get the scale moving again — without panicking and quitting.
6 min read
Side effects
How to manage nausea on GLP-1 medications: the week-one survival guide
Nausea is the #1 reason people quit a GLP-1 in month one. Most of it is preventable — here is the protocol that gets ~80% of my patients past the worst of it without a dose drop.
7 min read
Medications
Switching from Ozempic to Wegovy: a step-by-step guide
Both are semaglutide, but the doses, indications, and insurance coverage differ. Here is how to make the switch without losing weeks of progress.
7 min read
Weight management
GLP-1 and muscle loss: how to prevent it (protein + strength)
Up to 40% of weight lost on a GLP-1 can be muscle if you do nothing. With the right protein target and 2 strength sessions a week, that drops to under 15%.
7 min read
Getting started
What to expect on a GLP-1, month by month: the realistic timeline
The first 6 months on semaglutide or tirzepatide follow a predictable arc — but only if you know what to look for. Here is the month-by-month playbook.
8 min read
Lifestyle
Traveling with a GLP-1: TSA, time zones, and fridge access
Pen, ice pack, prescription label, and a calm answer for the TSA agent. Here is how to travel with semaglutide or tirzepatide without losing a dose.
5 min read